Morgan Stanley - Dec 31, 2024 SCHEDULE 13G Report for Apellis Pharmaceuticals, Inc. Common Stock (APLS)

Filing Manager
Morgan Stanley
Reporting Manager
Morgan Stanley
Security
Apellis Pharmaceuticals, Inc. Common Stock
Symbol
APLS
Shares outstanding
125M shares
Disclosed Ownership
9.59M shares
Ownership
7.7%
Form type
SCHEDULE 13G
Date filed
2/3/2025, 01:09 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Morgan Stanley 7.7% 9.59M 0 9.58M Christopher O'Hara Authorized Signatory, Morgan Stanley
Morgan Stanley Capital Services LLC 6.3% 7.8M 0 7.8M Christopher O'Hara Authorized Signatory, Morgan Stanley Capital Services LLC